Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Clinical Lung Cancer
|
January 1, 2004
Placebo-controlled trial of bexarotene, a retinoid x receptor agonist, as maintenance therapy for patients treated with chemotherapy for advanced non-small-cell lung cancer
N Rizvi, M J Hawkins, P D Eisenberg, et al.
The Journal of Urology
|
May 1, 1995
The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer
D D Daliani, P D Eisenberg, J Weems, et al.
Cancer
|
July 1, 1996
A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy
D S Ettinger, P D Eisenberg, D Fitts, et al.
Blood
|
May 1, 1980
Erythropoietic stress, macrocytosis, and hemoglobin switching in HbAA sheep
N Mohandas, M R Clark, J L Wyatt, et al.
Pharmacotherapy
|
January 1, 1990
A multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac tromethamine, acetaminophen plus codeine, and placebo in cancer pain
R W Carlson, R A Borrison, H B Sher, et al.
Journal of Neuro-Oncology
|
March 1, 1997
Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study
F Hochberg, M Prados, C Russell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1989
Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group
F H Valone, M A Friedman, P S Wittlinger, et al.
Clinical Therapeutics
|
November 1, 1995
Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy
J DiBenedetto, L X Cubeddu, T Ryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Clinical evaluation of MGI 209, an anesthetic, film-forming agent for relief from painful oral ulcers associated with chemotherapy
F G LeVeque, J B Parzuchowski, G C Farinacci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
M J Moore, J Hamm, J Dancey, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Clinical Lung Cancer
|
January 1, 2004
Placebo-controlled trial of bexarotene, a retinoid x receptor agonist, as maintenance therapy for patients treated with chemotherapy for advanced non-small-cell lung cancer
N Rizvi, M J Hawkins, P D Eisenberg, et al.
The Journal of Urology
|
May 1, 1995
The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer
D D Daliani, P D Eisenberg, J Weems, et al.
Cancer
|
July 1, 1996
A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy
D S Ettinger, P D Eisenberg, D Fitts, et al.
Blood
|
May 1, 1980
Erythropoietic stress, macrocytosis, and hemoglobin switching in HbAA sheep
N Mohandas, M R Clark, J L Wyatt, et al.
Pharmacotherapy
|
January 1, 1990
A multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac tromethamine, acetaminophen plus codeine, and placebo in cancer pain
R W Carlson, R A Borrison, H B Sher, et al.
Journal of Neuro-Oncology
|
March 1, 1997
Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study
F Hochberg, M Prados, C Russell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1989
Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group
F H Valone, M A Friedman, P S Wittlinger, et al.
Clinical Therapeutics
|
November 1, 1995
Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy
J DiBenedetto, L X Cubeddu, T Ryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Clinical evaluation of MGI 209, an anesthetic, film-forming agent for relief from painful oral ulcers associated with chemotherapy
F G LeVeque, J B Parzuchowski, G C Farinacci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
M J Moore, J Hamm, J Dancey, et al.
Page
of 2